Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/15956968

Br. J. Cancer 2005 Jun 20 92 12 2266-77

Download in:

View as

General Info

PMID
15956968